H Stewart Parker insider trades: Sangamo Therapeutics (SGMO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where H reports to the SEC
and 2 more companies
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 1, 2022 | SGMO | ↑ Buy | 5,000 | $3.60 | $18K | Direct | Jun 3, 2022 (2d) |
| Mar 18, 2020 | SGMO | ↑ Buy | 3,000 | $5.20 | $16K | Direct | Mar 19, 2020 (1d) |
| Nov 14, 2018 | SGMO | ↑ Buy | 2,000 | $9.00 | $18K | Direct | Nov 15, 2018 (1d) |
| Sep 7, 2018 | SGMO | ↑ Buy | 2,000 | $13.52 | $27K | Direct | Sep 7, 2018 (0d) |
| Aug 9, 2011 | OGXI | ↑ Buy | 3,000 | $10.09 | $30K | Direct | Aug 9, 2011 (0d) |
| Sep 5, 2006 | TGEN | ↑ Buy | 10,000 | $1.99 | $20K | Direct | Sep 5, 2006 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SGMO insiders
Open-market trades in the last 12 months
About H Stewart Parker's insider trades
H Stewart Parker is an insider at Sangamo Therapeutics (SGMO). Since Sep 5, 2006, H has reported 6 open-market purchases worth $129K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (38 filings), option exercises (6 filings), other transactions (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SGMO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.